Xynos Konstantinos
SEC insider (Form 3/4/5 filer). CIK 0001956241. Chief Medical Officer at Replimune Group, Inc. (REPL). 8 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in WOBURN, MA.
Companies Xynos Konstantinos has filed insider reports for
- Replimune Group, Inc. (REPL): Officer, Chief Medical Officer
Xynos Konstantinos
CIK: 0001956241
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Replimune Group, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Aug 10, 2026REPL
Replimune Group, Inc.
SaleDirect11.4K shares at avg. $12.97$148K - May 18, 2026REPL
Replimune Group, Inc.
SaleDirect14K shares at avg. $5.08$71K - Apr 1, 2026REPL
Replimune Group, Inc.
AwardDirect50K shares- - Dec 19, 2025REPL
Replimune Group, Inc.
AwardDirect60K shares- - Nov 17, 2025REPL
Replimune Group, Inc.
SaleDirect7.2K shares at avg. $9.10$66K - May 20, 2025REPL
Replimune Group, Inc.
SaleDirect8K shares at avg. $8.06$64K - Apr 1, 2025REPL
Replimune Group, Inc.
AwardDirect45K shares- - Nov 18, 2024REPL
Replimune Group, Inc.
SaleDirect7.2K shares at avg. $10.78$78K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | REPL Replimune Group, Inc. | Sale | 11,447 | $12.97 | $148,468 | Direct |
| May 18, 2026 | REPL Replimune Group, Inc. | Sale | 14,023 | $5.08 | $71,237 | Direct |
| Apr 1, 2026 | REPL Replimune Group, Inc. | Award | 50,000 | - | $0 | Direct |
| Dec 19, 2025 | REPL Replimune Group, Inc. | Award | 60,000 | - | - | Direct |
| Nov 17, 2025 | REPL Replimune Group, Inc. | Sale | 7,248 | $9.10 | $65,957 | Direct |
| May 20, 2025 | REPL Replimune Group, Inc. | Sale | 7,952 | $8.06 | $64,093 | Direct |
| Apr 1, 2025 | REPL Replimune Group, Inc. | Award | 45,000 | - | - | Direct |
| Nov 18, 2024 | REPL Replimune Group, Inc. | Sale | 7,246 | $10.78 | $78,112 | Direct |
1-8 of 8 transactions